A comprehensive analysis of metastatic disease following surgery for clinically localized cutaneous melanoma
This study is the first large analysis to guide the use of imaging for cutaneous melanoma. Among patients with clinically node negative disease, metastatic disease is uncommon, and brain metastases are exceedingly rare. Further investigation could promote a tailored approach to metastatic workups guided by individual risk factors.
Authors
- Gary N. Schwartz (ORCID: https://orcid.org/0000-0003-2537-9531)
- Alexander W. Loftus (ORCID: https://orcid.org/0000-0002-6421-7896)
- Jeremy S. Bordeaux (ORCID: https://orcid.org/0000-0002-7010-7730)
- Christina S. Boutros (ORCID: https://orcid.org/0000-0003-3802-9055)
- Ankit Mangla (ORCID: https://orcid.org/0000-0002-6789-4315)
- Richard S. Hoehn (ORCID: https://orcid.org/0000-0003-1455-6758)
- John B. Ammori (ORCID: https://orcid.org/0000-0003-2131-0369)
- Luke Daniel Rothermel (ORCID: https://orcid.org/0000-0001-5700-8028)
- Hanna Kakish
- Iris Yeong- Fung Sheng (ORCID: https://orcid.org/0009-0007-4999-6733)
- Omkar S Pawar (ORCID: https://orcid.org/0009-0005-0359-0223)
Institutions
- Cleveland Clinic (US)
- University Hospitals of Cleveland (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1093/jnci/djae216
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00